Stille AB (STIL.ST)
- Previous Close
214.00 - Open
219.00 - Bid 217.00 x --
- Ask 220.00 x --
- Day's Range
214.00 - 220.00 - 52 Week Range
179.50 - 275.00 - Volume
1,643 - Avg. Volume
11,110 - Market Cap (intraday)
1.977B - Beta (5Y Monthly) 0.65
- PE Ratio (TTM)
32.64 - EPS (TTM)
6.74 - Earnings Date Jul 17, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date May 8, 2023
- 1y Target Est
261.00
Stille AB develops, manufactures, and distributes medical technology products in Sweden and internationally. It operates through the Surgical Instruments and Surgical Tables segments. The Surgical Instruments segment offers surgical scissors, including SuperCut, eye, blepharoplasty, operating, vascular, tenotomy, and face-lift scissors; colon, gall duct, multi-purpose, tangential occlusion, peripheral vascular, and anastomosis clamps; skin and nerve hooks, retractors, rib spreaders, self-retaining and trachea retractors, and nasal specula; and dressing, diathermy, knot-holding, tissue, iris, dura, and vascular forceps under the STILLE, Fehling, and S&T brands. Its Surgical Tables segment provides C-arm tables, which are surgical tables used in ERCP/abdominal fluoroscopy, neuro/spine, pain management, urology, and vascular procedures under the imagiQ and MedStone brands. The company also offers instrument care education, repair and maintenance, and inspection services. Stille AB was founded in 1841 and is headquartered in Torshälla, Sweden.
www.stille.seRecent News: STIL.ST
View MorePerformance Overview: STIL.ST
Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: STIL.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: STIL.ST
View MoreValuation Measures
Market Cap
1.92B
Enterprise Value
1.83B
Trailing P/E
31.75
Forward P/E
24.63
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.44
Price/Book (mrq)
2.86
Enterprise Value/Revenue
3.27
Enterprise Value/EBITDA
23.56
Financial Highlights
Profitability and Income Statement
Profit Margin
10.81%
Return on Assets (ttm)
6.86%
Return on Equity (ttm)
9.18%
Revenue (ttm)
559.56M
Net Income Avi to Common (ttm)
60.48M
Diluted EPS (ttm)
6.74
Balance Sheet and Cash Flow
Total Cash (mrq)
148.61M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
38.68M